| | | | | | | | | Sponsored | | Access an evolving library of microorganisms for assay development and analytical studies. Select from available strains or work with our experts on custom growth to support feasibility, LOD, inclusivity, exclusivity, cross-reactivity, and other performance studies. Available in a variety of formats, including non-infectious viral lysates, live and heat inactivated culture fluids, purified DNA, and more. |
|
|
| | |
| |
| | |
|
|
| | | | | | BNP and NT-proBNP are well established in heart failure diagnosis—but could they tell us more? This October CE article explores their prognostic value and what these biomarkers may reveal about future cardiovascular risk. |
|
|
|
| |
| | |
|
|
| | | | | | The U.S. Food and Drug Administration recently launched an initiative to recruit new advisory committee members. The goal of this action is to add a broader range of qualified voices and perspectives to its committees and increase participation, according to an announcement. |
|
|
|
| |
| | |
|
|
| | | | | | Dr. Leslie Saltzman of Labcorp discusses the Marker Genetic Health Panel, who may benefit from hereditary genetic testing, and how it can provide insight into inherited health risks. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Most of what determines how an assay performs is decided before you run your first qPCR reaction, sequence a sample, or build an immunoassay or flow cytometry panel. The Assay Development Handbook covers the pre-analytical decisions that get locked in early and how to make them before they're permanent. |
|
|
| | |
| |
| | |
|
|
| | | | | | The Global TB Clinical and Educational Summit, hosted by QIAGEN, gathers international experts to discuss TB prevention, screening, drug resistance, and access to care amid funding challenges, emphasizing a unified global effort. |
|
|
|
| |
| | |
|
|
| | | | | | Showcase the people and accomplishments behind your laboratory’s success. Nominate your lab for MLO’s 2027 Lab of the Year award by January 15, 2027. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|